Asunaprevir-containing regimens for the treatment of hepatitis C virus infection.

about

Daclatasvir and asunaprevir treatment in patients with severe liver fibrosis by HCV genotype 1b infection: Real world data.Urgency to treat patients with chronic hepatitis C in Asia.Population Pharmacokinetic Analysis of Asunaprevir in Subjects with Hepatitis C Virus Infection.

P2860

Q31170657-C45309B0-06BA-46CB-935C-FA13A93DF7C1 Q39049155-BAEA8939-7373-494A-B823-026DC49BEC68 Q54246949-E1BD7CB1-4E52-4FC0-9A83-F9B810140074

P2860

Asunaprevir-containing regimens for the treatment of hepatitis C virus infection.

Item

http://www.wikidata.org/entity/Q38244931

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Asunaprevir-containing regimens for the treatment of hepatitis C virus infection.

@en

type

Item

label

Asunaprevir-containing regimens for the treatment of hepatitis C virus infection.

@en

prefLabel

Asunaprevir-containing regimens for the treatment of hepatitis C virus infection.

@en

P1476

Asunaprevir-containing regimens for the treatment of hepatitis C virus infection

@en

P2093

Sheng-Shun Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Boceprevir for previously treated chronic HCV genotype 1 infection

Hepatitis C virus hijacks host lipid metabolism

Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potential

Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management

A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3

Critical Role of Cyclophilin A and Its Prolyl-Peptidyl Isomerase Activity in the Structure and Function of the Hepatitis C Virus Replication Complex

Discovery and early clinical evaluation of BMS-605339, a potent and orally efficacious tripeptidic acylsulfonamide NS3 protease inhibitor for the treatment of hepatitis C virus infection

Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

P304

9-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17474124.2014.953930

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jia-Horng Kao

P577

2014-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265213029

http://www.w3.org/2001/XMLSchema#string

P698

25174254

http://www.w3.org/2001/XMLSchema#string

Asunaprevir-containing regimens for the treatment of hepatitis C virus infection.

about

P2860

P2860

Asunaprevir-containing regimens for the treatment of hepatitis C virus infection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698